Literature DB >> 25110522

Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience.

Aaron U Blackham1, Katrina Swett2, Edward A Levine1, Perry Shen1.   

Abstract

Over the past 30 years, the treatment of metastatic colorectal cancer to the liver has undergone major changes. Once considered terminal and incurable, the prognosis of patients with colorectal hepatic metastases has seen dramatic improvements using modern multimodality therapy and now long-term survival and even cure are possible in some patients. Despite the advances seen in systemic therapy, hepatic resection offers the longest survival potential and remains the only curative option. Based on long-term outcomes and the improved safety of hepatic resection using modern operative techniques and critical care support, an aggressive locoregional approach to colorectal hepatic metastasis has become the standard of care. This article focuses on the management of colorectal hepatic metastases and highlights the importance of multimodality therapy. We also report our 18-year experience treating patients with hepatic resection for colorectal metastases.

Entities:  

Year:  2013        PMID: 25110522      PMCID: PMC4124526          DOI: 10.2217/crc.12.80

Source DB:  PubMed          Journal:  Colorectal Cancer        ISSN: 1758-194X


  102 in total

1.  Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study.

Authors:  Daniel Jaeck; Hiroshi Nakano; Philippe Bachellier; Keiichiro Inoue; Jean-Christophe Weber; Elie Oussoultzoglou; Philippe Wolf; Marie-Pierre Chenard-Neu
Journal:  Ann Surg Oncol       Date:  2002-06       Impact factor: 5.344

2.  Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

Authors:  Chusilp Charnsangavej; Bryan Clary; Yuman Fong; Axel Grothey; Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2006-09-01       Impact factor: 5.344

3.  Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing.

Authors:  Peter-Michael Krieger; Dietmar Tamandl; Beata Herberger; Peter Faybik; Edith Fleischmann; Judith Maresch; Thomas Gruenberger
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

4.  Two-stage hepatectomy for multiple bilobar colorectal liver metastases.

Authors:  M Narita; E Oussoultzoglou; D Jaeck; P Fuchschuber; E Rosso; P Pessaux; E Marzano; P Bachellier
Journal:  Br J Surg       Date:  2011-06-28       Impact factor: 6.939

5.  Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.

Authors:  Camillo Aliberti; Giammaria Fiorentini; Pier Carlo Muzzio; Fabio Pomerri; Massimo Tilli; Sergio Dallara; Giorgio Benea
Journal:  Anticancer Res       Date:  2011-12       Impact factor: 2.480

6.  Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study.

Authors:  M Margaret Kemeny; Sudeshna Adak; Bruce Gray; John S Macdonald; Thomas Smith; Stuart Lipsitz; Elin R Sigurdson; Peter J O'Dwyer; Al B Benson
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

7.  Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Authors:  René Adam; Gerard Pascal; Denis Castaing; Daniel Azoulay; Valerie Delvart; Bernard Paule; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

8.  Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

Authors:  René Adam; Robbert J de Haas; Dennis A Wicherts; Thomas A Aloia; Valérie Delvart; Daniel Azoulay; Henri Bismuth; Denis Castaing
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

9.  Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Authors:  Hiroshi Nakano; Elie Oussoultzoglou; Edoardo Rosso; Selenia Casnedi; Marie-Pierre Chenard-Neu; Patrick Dufour; Philippe Bachellier; Daniel Jaeck
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

Review 10.  Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

Authors:  Simone Mocellin; Pierluigi Pilati; Mario Lise; Donato Nitti
Journal:  J Clin Oncol       Date:  2007-12-10       Impact factor: 44.544

View more
  1 in total

1.  Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer.

Authors:  Shukui Qin; Rui-Hua Xu; Lin Shen; Jianming Xu; Yuxian Bai; Lei Yang; Yanhong Deng; Zhen-Dong Chen; Haijun Zhong; Hongming Pan; Weijian Guo; Yongqian Shu; Ying Yuan; Jianfeng Zhou; Nong Xu; Tianshu Liu; Dong Ma; Changping Wu; Ying Cheng; Donghui Chen; Wei Li; Sanyuan Sun; Zhuang Yu; Peiguo Cao; Haihui Chen; Jiejun Wang; Shubin Wang; Hongbing Wang; Ning Wang; Bin Zhang; Qiang Zhang; Weiguo Su; Xiaojun Guo; Jin Li
Journal:  Onco Targets Ther       Date:  2021-08-11       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.